thiazoles has been researched along with mart-1 antigen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agouna-Deciat, O; Banchereau, J; Blanck, JP; Cao, Y; Flamar, AL; Klechevsky, E; Klucar, P; Liu, M; O'Bar, A; Palucka, AK; Reiter, Y; Thompson-Snipes, L; Zurawski, G; Zurawski, S | 1 |
1 other study(ies) available for thiazoles and mart-1 antigen
Article | Year |
---|---|
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
Topics: Animals; Antibodies, Monoclonal; Antigens; Antigens, Neoplasm; B-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cross-Priming; Dendritic Cells; Flow Cytometry; gag Gene Products, Human Immunodeficiency Virus; Humans; Langerhans Cells; Lectins, C-Type; MART-1 Antigen; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Monocytes; Neoplasm Proteins; Quinolines; Receptors, Immunologic; Thiazoles; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2010 |